Influence of cerebral white matter hyperintensities on cognitive impairment in elderly medical patients

Geriatrics and Gerontology International

Volumn 17, Issue 10, 2017, Pages 1488-1493

  Shibata, Koichi ^a   Nishimura, Yoshiko ^a   Otsuka, Kuniaki ^a   Sakura, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

cognitive impairment; elderly; medical patient; Mini Mental State Examination; white matter hyperintensities

Indexed keywords

AGED; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; COGNITIVE DEFECT; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GERIATRIC DEPRESSION SCALE; HUMAN; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VERY ELDERLY; WHITE MATTER; WHITE MATTER HYPERINTENSITY; ATROPHY; BRAIN DISEASE; COMPLICATION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

AGED; ATROPHY; BASAL GANGLIA; BRAIN DISEASES; COGNITIVE DYSFUNCTION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; WHITE MATTER;

EID: 85034432044     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12900     Document Type: Article

References (30)

1. Tuijl JP, Scholte EM, de Craen AJ, van der Mast RC. Screening for cognitive impairment in older general hospital patients: comparison of the Six-Item Cognitive Impairment Test with the Mini-Mental State Examination. Int J Geriatr Psychiatry 2012; 27: 755–762.
2. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010; 341: c3666.
3. Wardlaw JM, Allerhand M, Doubal FN et al. Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities. Neurology 2014; 82: 1331–1338.
4. Kral BG, Nyquist P, Vaidya D et al. Relation of subclinical coronary artery atherosclerosis to cerebral white matter disease in healthy subjects from families with early-onset coronary artery disease. Am J Cardiol 2013; 112: 747–752.
5. Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol 2013; 24: 353–363.
6. Granger CV, Albrecht GL, Hamilton BB. Outcome of comprehensive medical rehabilitation: measurement by PULSES profile and the Barthel Index. Arch Phys Med Rehabil 1979; 60: 145–154.
7. Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982–992.
8. Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011; 80: 17–28.
9. Yesavage JA, Brink TL, Rose TL et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-1983; 17: 37–49.
10. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944.
12. Román GC, Tatemichi TK, Erkinjuntti T et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250–260.
13. Scheltens P, Barkhof F, Leys D et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993; 114: 7–12.
14. Brickman AM, Honig LS, Scarmeas N et al. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol 2008; 65: 1202–1208.
15. De Groot JC, De Leeuw FE, Oudkerk M et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002; 52: 335–341.
16. Silbert LC, Howieson DB, Dodge H, Kaye JA. Cognitive impairment risk: white matter hyperintensity progression matters. Neurology 2009; 73: 120–125.
17. Kim S, Kim MJ, Kim S et al. Gender differences in risk factors for transition from mild cognitive impairment to Alzheimer's disease: A CREDOS study. Compr Psychiatry 2015; 62: 114–122.
18. Tokuchi R, Hishikawa N, Kurata T et al. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition. J Neurol Sci 2014; 346: 288–292.
19. Miwa K, Tanaka M, Okazaki S et al. Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease. Neurology 2014; 82: 1051–1057.
20. Murray A, McNeil C, Salarirad S et al. Brain hyperintensity location determines outcome in the triad of impaired cognition, physical health and depressive symptoms: A cohort study in late life. Arch Gerontol Geriatr 2016; 63: 49–54.
21. Benisty S, Gouw AA, Porcher R et al. Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study. J Neurol Neurosurg Psychiatry 2009; 80: 478–483.
22. Mayda AB, Westphal A, Carter CS, DeCarli C. Late life cognitive control deficits are accentuated by white matter disease burden. Brain 2011; 134: 1673–1683.
23. Makin SD, Turpin S, Dennis MS, Wardlaw JM. Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes. J Neurol Neurosurg Psychiatry 2013; 84: 893–900.
24. Bastos Leite AJ, van der Flier WM, van Straaten EC, Scheltens P, Barkhof F. Infratentorial abnormalities in vascular dementia. Stroke 2006; 37: 105–110.
25. Helmer C, Stengel B, Metzger M et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology 2011; 77: 2043–2051.
26. Umemura T, Kawamura T, Sakakibara T, Mashita S, Hotta N, Sobue G. Microalbuminuria is independently associated with deep or infratentorial brain microbleeds in hypertensive adults. Am J Hypertens 2012; 25: 430–436.
27. O'Brien JT, Firbank MJ, Krishnan MS et al. White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study. Am J Geriatr Psychiatry 2006; 14: 834–841.
28. Tokuchi R, Deguchi K, Yamashita T, Abe K. Impact of combined medial temporal atrophy and white matter lesions on the cognitive and emotional functions in Alzheimer's disease patients. Nihon Ronen Igakkai Zasshi 2014; 51: 342–349.
29. Kimura N, Nakama H, Nakamura K, Aso Y, Kumamoto T. Effect of white matter lesions on brain perfusion in Alzheimer's disease. Dement Geriatr Cogn Disord 2012; 34: 256–261.
30. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987; 149: 351–356.